159 related articles for article (PubMed ID: 17109256)
1. Vitamin E reduces antidepressant-related beta-adrenoceptor down-regulation in cultured cells. Comparable effects on St. John's wort and tricyclic antidepressant treatment.
De Marchis GM; Bürgi S; Kientsch U; Honegger UE
Planta Med; 2006 Dec; 72(15):1436-7. PubMed ID: 17109256
[TBL] [Abstract][Full Text] [Related]
2. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells.
Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE
Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078
[TBL] [Abstract][Full Text] [Related]
3. Hypericum perforatum L. (St John's wort) extract Ze 117 inhibits dopamine re-uptake in rat striatal brain slices. An implication for use in smoking cessation treatment?
Ruedeberg C; Wiesmann UN; Brattstroem A; Honegger UE
Phytother Res; 2010 Feb; 24(2):249-51. PubMed ID: 19585471
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of St. Johns wort extract].
Müller WE; Singer A; Wonnemann M
Praxis (Bern 1994); 2000 Dec; 89(50):2111-21. PubMed ID: 11155494
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.
Kumar A; Singh A
Planta Med; 2007 Oct; 73(13):1358-64. PubMed ID: 17918039
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice.
Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S
J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766
[TBL] [Abstract][Full Text] [Related]
7. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex.
Simbrey K; Winterhoff H; Butterweck V
Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids of St. John's Wort reduce HPA axis function in the rat.
Butterweck V; Hegger M; Winterhoff H
Planta Med; 2004 Oct; 70(10):1008-11. PubMed ID: 15490333
[TBL] [Abstract][Full Text] [Related]
9. The effects of St. John's wort extract and amitriptyline on autonomic responses of blood vessels and sweat glands in healthy volunteers.
Siepmann M; Kirch W; Krause S; Joraschky P; Mueck-Weymann M
J Clin Psychopharmacol; 2004 Feb; 24(1):79-82. PubMed ID: 14709951
[TBL] [Abstract][Full Text] [Related]
10. The prototypic antidepressant drug, imipramine, but not Hypericum perforatum (St. John's Wort), reduces HPA-axis function in the rat.
Frost P; Bornstein S; Ehrhart-Bornstein M; O'Kirwan F; Hutson C; Heber D; Go V; Licinio J; Wong ML
Horm Metab Res; 2003 Oct; 35(10):602-6. PubMed ID: 14605995
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies in an herbal drug combination of St. John's Wort (Hypericum perforatum) and passion flower (Passiflora incarnata): in vitro and in vivo evidence of synergy between Hypericum and Passiflora in antidepressant pharmacological models.
Fiebich BL; Knörle R; Appel K; Kammler T; Weiss G
Fitoterapia; 2011 Apr; 82(3):474-80. PubMed ID: 21185920
[TBL] [Abstract][Full Text] [Related]
12. Preserved pharmacological activity of hepatocytes-treated extracts of valerian and St. John's wort.
Simmen U; Saladin C; Kaufmann P; Poddar M; Wallimann C; Schaffner W
Planta Med; 2005 Jul; 71(7):592-8. PubMed ID: 16041642
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair.
Kulkarni SK; Akula KK; Deshpande J
Pharmacology; 2012; 89(1-2):83-90. PubMed ID: 22343362
[TBL] [Abstract][Full Text] [Related]
14. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
Bukhari IA; Dar A
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522
[TBL] [Abstract][Full Text] [Related]
15. [High dose St. John's wort extract as a phytogenic antidepressant].
Kasper S; Schulz V
Wien Med Wochenschr; 1999; 149(8-10):191-6. PubMed ID: 10483679
[TBL] [Abstract][Full Text] [Related]
16. A pilot randomised, open, uncontrolled, clinical study of two dosages of St John's wort (Hypericum perforatum) herb extract (LI-160) as an aid to motivational/behavioural support in smoking cessation.
Barnes J; Barber N; Wheatley D; Williamson EM
Planta Med; 2006 Mar; 72(4):378-82. PubMed ID: 16557483
[TBL] [Abstract][Full Text] [Related]
17. Effects of St. John's wort extract and single constituents on stress-induced hyperthermia in mice.
Grundmann O; Kelber O; Butterweck V
Planta Med; 2006 Dec; 72(15):1366-71. PubMed ID: 17051457
[TBL] [Abstract][Full Text] [Related]
18. In vitro receptor screening of pure constituents of St. John's wort reveals novel interactions with a number of GPCRs.
Butterweck V; Nahrstedt A; Evans J; Hufeisen S; Rauser L; Savage J; Popadak B; Ernsberger P; Roth BL
Psychopharmacology (Berl); 2002 Jul; 162(2):193-202. PubMed ID: 12110997
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
Brattström A
Phytomedicine; 2009 Apr; 16(4):277-83. PubMed ID: 19299116
[TBL] [Abstract][Full Text] [Related]
20. St. John's wort - an overview.
Linde K
Forsch Komplementmed; 2009 Jun; 16(3):146-55. PubMed ID: 19657198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
